April 6 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1330 GMT on Monday:
Neurocrine Biosciences <NBIX.O> will acquire rare-disease drugmaker Soleno Therapeutics <SLNO.O> for $2.9 billion in cash, the companies said, marking the neuroscience-focused drugmaker's expansion into metabolic disorders.
nL6N40P02H
Singapore-based Olam Group
nL4N40O043
KNDS France - a unit of German tank maker KNDS - has completed its takeover of French company Texelis Defense for an undisclosed financial amount, said KNDS France.
nL6N40M0LK